The role of inflammasome in chronic viral hepatitis
Frontiers in Cellular and Infection Microbiology · 2024
DOI: 10.3389/fcimb.2024.1382029 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2024. Verfasst von Pin Wan und 12 weiteren Autor:innen. Beteiligte Einrichtung: Hubei Key Laboratory of Cognitive and Affective Disorders, Institute of Biomedical Sciences, School of Medicine, Jianghan University, Wuhan, China. Hauptthemen laut MEDLINE: Inflammasomes, Hepatitis C, Chronic, NLR Family, Pyrin Domain-Containing 3 Protein, Hepacivirus. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Infections of hepatotropic viruses cause a wide array of liver diseases including acute hepatitis, chronic hepatitis and the consequently developed cirrhosis and hepatocellular carcinoma (HCC). Among the five classical hepatotropic viruses, hepatitis B virus (HBV) and hepatitis C virus (HCV) usually infect human persistently and cause chronic hepatitis, leading to major troubles to humanity. Previous studies have revealed that several types of inflammasomes are involved in the infections of HBV and HCV. Here, we summarize the current knowledge about their roles in hepatitis B and C. NLRP3 inflammasome can be activated and regulated by HBV and HCV. It is found to exert antiviral function or mediates inflammatory response in viral infections depending on different experimental models. Besides NLRP3 inflammasome, IFI16 and AIM2 inflammasomes participate in the pathological process of hepatitis B, and NALP3 inflammasome may sense HCV infection in hepatocytes. The inflammasomes affect the pathological process of viral hepatitis through its downstream secretion of inflammatory cytokines interleukin-1β (IL-1β) and IL-18 or induction of pyroptosis resulting from cleaved gasdermin D (GSDMD). However, the roles of inflammasomes in different stages of viral infection remains mainly unclear. More proper experimental models of viral hepatitis should be developed for specific studies in future, so that we can understand more about the complexity of inflammasome regulation and multifunction of inflammasomes and their downstream effectors during HBV and HCV infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hubei Key Laboratory of Cognitive and Affective Disorders, Institute of Biomedical Sciences, School of Medicine, Jianghan University, Wuhan, China.
- Foshan Institute of Medical Microbiology, Foshan, China.
- Wuhan Jinyintan Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China.
- Institute of Medical Microbiology, Department of Immunology and Microbiology, College of Life Science and Technology, Jinan University, Guangzhou, China.
- Laboratory of Viral Pathogenesis & Infection Prevention and Control (Jinan University), Ministry of Education, Guangzhou, China.
- National "111" Center for Cellular Regulation and Molecular Pharmaceutics, Key Laboratory of Fermentation Engineering (Ministry of Education), Hubei Provincial Cooperative Innovation Center of Industrial Fermentation, H…
Zitieren
APA
Wan, P., Yang, G., Cheng, Q., Zhang, X., Yue, Z., Li, M., Liu, C., Yi, Q., Jia, Y., Liu, J., Xing, X., Sun, B., & Li, Y. (2024). The role of inflammasome in chronic viral hepatitis. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2024.1382029
Vancouver
Wan P, Yang G, Cheng Q, Zhang X, Yue Z, Li M, et al. The role of inflammasome in chronic viral hepatitis. Frontiers in Cellular and Infection Microbiology. 2024. doi:10.3389/fcimb.2024.1382029
BibTeX
@article{Wan2024,
author = {Wan, Pin and Yang, Ge and Cheng, Qi and Zhang, Xuelong and Yue, Zhaoyang and Li, Moran and Liu, Chunlin and Yi, Qian and Jia, Yaling and Liu, Jinbiao and Xing, Xiwen and Sun, Binlian and Li, Yongkui},
title = {The role of inflammasome in chronic viral hepatitis},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2024},
doi = {10.3389/fcimb.2024.1382029}
}
EUVIMED